Abstract
Overactive bladder (OAB) is a prevalent condition that substantially degrades patient quality of life. Acupuncture is recognized as an effective therapeutic approach for various urological diseases. However, there is limited evidence validating the effectiveness and safety of acupuncture for OABs.
To assess the therapeutic efficacy of acupuncture for OAB and to investigate the potential mechanisms by analyzing its effects on relevant urinary biomarkers.
This is a randomized, participants and outcome assessors blinded, sham acupuncture controlled trial. A total of 110 patients with OABs will be randomly divided in a 1:1 ratio between the acupuncture and sham acupuncture groups. Participants in the acupuncture group will undergo 30-min authentic acupuncture, while their counterparts in the sham acupuncture group will undergo sham acupuncture needling non-acupoints superficially three times weekly for a duration of 8 weeks. The two co-primary outcomes will be the change in the mean number of micturitions per 24 h from baseline to the end of the 8-week treatment and 20-week follow-up. The secondary outcomes will encompass the change in Overactive Bladder Symptom Score, Overactive Bladder Questionnaire Short Form, and average 24 h values of urgency, daytime micturition, nocturia, and mean volume voided per micturition from baseline to weeks 8 and 20. Urinary nerve growth factor, brain-derived neurotrophic factor, and monocyte chemoattractant protein-1 levels will be measured at baseline and week 8. Adverse events will also be documented.
The results of this trial will provide evidence for the effectiveness and safety of acupuncture in the management of OAB.
References
1
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–178.
2
Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–1315.
3
Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71–76.
4
Przydacz M, Golabek T, Dudek P, Lipinski M, Chlosta P. Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study. Sci Rep. 2020;10(1):19819.
5
Santander J, Plata M, Zuluaga L, et al. What is the real burden of the overactive bladder? Results from a national prevalence study. Neurourol Urodyn. 2022;41(4):926–934.
6
Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11):1388–1395.
7
Plata M, Bravo-Balado A, Robledo D, et al. Prevalence of lower urinary tract symptoms and overactive bladder in men and women over 18 years old: the Colombian overactive bladder and lower urinary tract symptoms (COBaLT) study. Neurourol Urodyn. 2019;38(1):200–207.
8
Lin XD, Lin N, Ke ZB, Xu N, Jiang P, Li H. Effects of overactive bladder syndrome on female sexual function. Medicine (Baltim). 2021;100(20):e25761.
9
Mehr AA, Kreder KJ, Lutgendorf SK, Ten Eyck P, Greimann ES, Bradley CS. Daily symptom associations for urinary urgency and anxiety, depression and stress in women with overactive bladder. Int Urogynecol J. 2022;33(4):841–850.
10
Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU Guideline Amendment 2019. J Urol. 2019;202(3):558–563.
11
Enemchukwu EA, Subak LL, Markland A. Barriers and facilitators to overactive bladder therapy adherence. Neurourol Urodyn. 2022;41(8):1983–1992.
12
Te Dorsthorst MJ, Heesakkers JPFA, van Balken MR. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients. Neurourol Urodyn. 2020;39(2):702–706.
13
Schulte-Baukloh H, Atamen-Grehn Ö, Knispel HH, Schlomm T, Weinberger S. Subjective outcome after discontinuation of botulinum toxin-a detrusor injection for lower urinary tract disorders: the majority suffers. Urol Int. 2023;107(3):263–272.
14
Groen J, Blok BF, Bosch JL. Sacral neuromodulation as treatment for refractory idiopathic urge urinary incontinence: 5-year results of a longitudinal study in 60 women. J Urol. 2011;186(3):954–959.
15
van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178(5):2029–2034.
16
Blanchet KD. Acupuncture: gaining acceptance in urology: proves effective for a number of chronic conditions. BJU Int. 2012;109(2):ⅱ–ⅳ.
17
Wang H, Lei X. Acupuncture for women with overactive bladder: perspective of traditional Chinese medicine and related mechanism. Int J Gen Med. 2023;16:1137–1148.
18
Gao Y, Zhou X, Dong X, Jia Q, Xie S, Pang R. Electroacupuncture for bladder function recovery in patients undergoing spinal anesthesia. Evid Based Complement Alternat Med. 2014;2014:892619.
19
Jin C, Zhou X, Pang R. Effect of electroacupuncture combined with tolterodine on treating female mixed urinary incontinence. J Wound Ostomy Cont Nurs. 2014;41(3):268–272.
20
Emmons SL, Otto L. Acupuncture for overactive bladder: a randomized controlled trial. Obstet Gynecol. 2005;106(1):138–143.
21
Aydoğmuş Y, Sunay M, Arslan H, Aydın A, Adiloğlu AK, Şahin H. Acupuncture versus solifenacin for treatment of overactive bladder and its correlation with urine nerve growth factor levels: a randomized, placebo-controlled clinical trial. Urol Int. 2014;93(4):437–443.
22
Zhang J, Cheng W, Cai M. Effects of electroacupuncture on overactive bladder refractory to anticholinergics: a single-blind randomised controlled trial. Acupunct Med. 2015;33(5):368–374.
23
Lin ZX, Chan NHT, Kwan YK, et al. A randomized controlled trial to assess the effectiveness and safety of acupuncture for overactive bladder: a study in Hong Kong population. Chin Med. 2020;15:108.
24
Chan AW, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
25
Hamasaki T, Evans SR, Asakura K. Design, data monitoring, and analysis of clinical trials with co-primary endpoints: a review. J Biopharm Stat. 2018;28(1):28–51.
26
Fang JQ, Zhao BX. Acupuncture and Moxibustion. 3rd ed. Beijing, China: People's Medical Publishing House; 2021.
27
Coyne KS, Thompson CL, Lai JS, Sexton CC. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn. 2015;34(3):255–263.
28
Homma Y, Fujimura T. Psychometric validation of the English version of the overactive bladder symptom score. Urology. 2014;84(1):46–50.
29
Gotoh M, Homma Y, Yokoyama O, Nishizawa O. Responsiveness and minimal clinically important change in overactive bladder symptom score. Urology. 2011;78(4):768–773.
30
Arlandis S, Ruiz MA, Errando C, et al. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form. Clin Drug Invest. 2012;32(8):523–532.
31
Blanker MH, Alma HJ, Devji TS, Roelofs M, Steffens MG, van der Worp H. Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care. BMJ Open. 2019;9(12):e032795.
32
Brucker BM, Lee RK, Newman DK. Optimizing nonsurgical treatments of overactive bladder in the United States. Urology. 2020;145:52–59.
33
Snedecor SJ. Review of economic value drivers of the treatment of overactive bladder. Pharmacoeconomics. 2018;36(9):1083–1092.
34
Hargreaves E, Baker K, Barry G, et al. Acupuncture for treating overactive bladder in adults. Cochrane Database Syst Rev. 2022;9(9):CD013519.
35
Filshie J, White A, Cummings M. Medical Acupuncture: A Western Scientific Approach. 2nd ed. Amsterdam, NL: Elsevier; 2016.
36
Huang W, Pach D, Napadow V, et al. Characterizing acupuncture stimuli using brain imaging with FMRI--a systematic review and meta-analysis of the literature. PLoS One. 2012;7(4):e32960.
37
Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA. 2017;317(24):2493–2501.
